CIPLA.NS Cipla Limited
INR·Price 1374.70·Mkt cap 1.11TComputed from the latest reported financials and the current market price.
Who's the real player?
A genuine play on this theme — most of its business sits right here.
Is the business healthy?
Shaky fundamentals — weak cash generation or a stretched balance sheet. Tread carefully.
- ⚠Weak FCF conversion (<50% of net income turns into free cash)
- Strong growth quality
- Healthy balance sheet
- Low leverage and high interest coverage
Are the smart people buying?
No ownership-change data for this stock. The score reflects heavy growth investment (capex) and buybacks, not visible insider buying.
- Insider net buys
- High institutional ownership
- Capex growth
What is management saying?
No earnings-call transcript or filings found for this stock.
Is the price right?
Intrinsic value 312.11 vs price 1374.70 — screens expensive on a cash-flow DCF (-77.3% to intrinsic). The base FCF growth assumption is 0%, which may not be realistic for a growing company.
| Intrinsic / share | 312.11 |
| Price | 1374.70 |
| Upside to intrinsic | -77.3% |
| Reverse-DCF implied g | 20.6% |
Base FCF 23.67B · growth 0.0% · discount 12.0% · terminal 5.0%.
Sensitivity — intrinsic value / share
Each cell is the intrinsic value at that growth (across →) and discount rate (down ↓). Center ★ is the base case. Cells green = above price (cheap), red = below (expensive).
| Growth rate → | |||||
|---|---|---|---|---|---|
| Disc ↓ ╲ g | -4% | -2% | 0% | 2% | 4% |
| 10% | 312.19 | 362.8 | 422.33 | 492.26 | 574.28 |
| 11% | 268.72 | 309.92 | 358.2 | 414.71 | 480.77 |
| 12% | 237.29 | 271.81 | ★ 312.11 | 359.12 | 413.9 |
| 13% | 213.41 | 242.96 | 277.33 | 317.28 | 363.69 |
| 14% | 194.58 | 220.29 | 250.09 | 284.61 | 324.6 |
Through the masters' eyes
Each investor's numeric rules, checked against this stock's metrics: exact math, no guesswork. Tap one to see which rules pass, fail, and what to judge yourself.
▶
Passes 2 of 2 of Peter Lynch's numeric checks. Still judge the non-numeric criteria below for yourself.
- Manageable debt (D/E ≤ 1.0) — now 0.02
- Solid liquidity (current ratio ≥ 1.5) — now 3.44
- A simple business you understand
- Which 'type' it is (fast grower, stalwart, cyclical…)
- A believable growth story
Couldn't check from available data: PEG ≤ 1 (growth cheap vs price) — not available; Earnings growth ≥ 15% — not available
▶
Passes 3 of 4 of Radhakishan Damani's numeric checks. Still judge the non-numeric criteria below for yourself.
- Very low debt (D/E ≤ 0.5) — now 0.02
- Consistent revenue (consistency ≥ 80%) — now 95.4%
- Positive net margin — now 14%
- High returns on capital (ROCE ≥ 18%) — now 13.7%
- A durable consumer franchise
- Pricing power
- A long runway, bought patiently
▶
Passes 2 of 3 of Rakesh Jhunjhunwala's numeric checks. Still judge the non-numeric criteria below for yourself.
- Net margin ≥ 10% — now 14%
- Conservative leverage (D/E ≤ 1.0) — now 0.02
- ROE ≥ 18% — now 11.3%
- A large, scalable opportunity
- Trustworthy, ambitious management
- Conviction to hold through volatility
Couldn't check from available data: Earnings growth ≥ 15% — not available
▶
Passes 3 of 5 of Warren Buffett's numeric checks. Still judge the non-numeric criteria below for yourself.
- Net margin ≥ 10% — now 14%
- Positive free cash flow — now 3.1%
- Conservative leverage (D/E ≤ 1.0) — now 0.02
- ROE ≥ 15% — now 11.3%
- Trades below intrinsic value (margin of safety ≥ 0) — now -340.4%
- A business you can understand
- A durable competitive moat
- Honest, capable management
▶
Passes 3 of 6 of Benjamin Graham's numeric checks. Still judge the non-numeric criteria below for yourself.
- Strong liquidity (current ratio ≥ 1.5) — now 3.44
- Debt below equity (D/E ≤ 1.0) — now 0.02
- Financially safe (Altman Z ≥ 3) — now 11.41
- P/E ≤ 15 — now 28.71
- P/B ≤ 1.5 — now 3.23
- Graham number: P/E × P/B ≤ 22.5 — now 92.7
- A long record of stable earnings
- An uninterrupted dividend history
▶
Passes 1 of 2 of Raamdeo Agrawal's numeric checks. Still judge the non-numeric criteria below for yourself.
- Longevity: revenue consistency ≥ 70% — now 95.4%
- Quality: ROCE ≥ 18% — now 13.7%
- Durability of the growth (longevity)
- Quality and honesty of management
Couldn't check from available data: Growth: earnings CAGR ≥ 15% — not available; Price: PEG ≤ 2 — not available
▶
Passes 1 of 2 of Vijay Kedia's numeric checks. Still judge the non-numeric criteria below for yourself.
- Manageable debt (D/E ≤ 1.0) — now 0.02
- ROE ≥ 15% — now 11.3%
- Ambitious, capable management
- A small company with a large opportunity
- Patience to hold for years
Couldn't check from available data: Strong earnings growth ≥ 20% — not available
▶
Passes 1 of 4 of Charlie Munger's numeric checks. Still judge the non-numeric criteria below for yourself.
- Conservative leverage (D/E ≤ 1.0) — now 0.02
- High returns on capital (ROCE ≥ 15%) — now 13.7%
- ROE ≥ 15% — now 11.3%
- Trades below intrinsic value (margin of safety ≥ 0) — now -340.4%
- A high-quality, understandable business
- A durable moat
- Management of integrity
Financial statements (INR)
↗ sourceCash-flow lines highlighted — we trust cash over reported profit.
| Line | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 277.12B | 271.45B | 254.47B | 224.73B | — |
| Operating income | 48.46B | 61.44B | 53.69B | 40.18B | — |
| EBITDA | 63.55B | 78.60B | 68.24B | 51.52B | — |
| Net income | 38.79B | 52.73B | 41.22B | 28.02B | — |
| Operating cash flow | 39.40B | 50.05B | 41.34B | 32.38B | — |
| Capex | -30.79B | -15.48B | -13.49B | -11.83B | — |
| Free cash flow | 8.61B | 34.57B | 27.85B | 20.55B | — |
| Total assets | 424.96B | 373.87B | 327.18B | 294.63B | — |
| Total equity | 344.32B | 311.93B | 267.06B | 234.08B | — |
| Total debt | 6.14B | 4.38B | 5.59B | 8.03B | — |
| Cash & equivalents | 10.18B | 5.89B | 6.40B | 6.28B | — |